Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Africa CDC says Congo Ebola outbreak still not under control

    November 16, 2026

    UAE and Timor-Leste presidents discuss stronger bilateral ties

    November 16, 2026

    UAE President, Arab League chief discuss regional security

    November 14, 2026
    • Home
    • Contact Us
    Penang HeraldPenang Herald
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Penang HeraldPenang Herald
    Home » OmniGuide Holdings Announces Successful Completion of Patient Study for Revolutionary iSTONE(TM) Laser-Guided Lithotripsy Technology
    ACCESS Newswire

    OmniGuide Holdings Announces Successful Completion of Patient Study for Revolutionary iSTONE(TM) Laser-Guided Lithotripsy Technology

    July 26, 2024
    Facebook Twitter Pinterest LinkedIn Telegram Tumblr Email

    BILLERICA, MA / ACCESSWIRE / July 26, 2024 / OmniGuide Holdings, Inc. (OGH) is thrilled to announce the successful completion of a groundbreaking patient study for its innovative iSTONE™ software, a laser-guided system designed for real-time automatic target identification in endoscopic stone lithotripsy. This advancement marks a significant milestone in the treatment of urolithiasis, promising a new era of precision and safety in kidney stone management.

    In August 2022, the German Federal Ministry of Education and Research recognized the potential of this pioneering technology, awarding LISA Laser Products GmbH, a subsidiary of OmniGuide Holdings based in Germany, a prestigious grant (Grant No. 13GW0628) to develop the iSTONE system further. The novel optical feedback technology at the heart of iSTONE has demonstrated a significant reduction in energy required during lithotripsy procedures in a porcine animal model, thereby minimizing the heat load and potential temperature increase in the kidney. This innovation not only preserves the integrity of the organ but also protects it from permanent postoperative damage.

    The results from the animal study are compelling, showing the potential for a reduction of over 50% in the energy applied and the risk of kidney damage compared to the traditional Gold Standard Holmium Therapy.1 “Our unique approach underscores our patient-focused mission and is set to redefine laser-assisted lithotripsy,” stated Tullio Cappelletto, Global Director of Marketing and Sales at OmniGuide Holdings.

    The OmniGuide Digital Innovation Institute, with its team of exceptional developers and engineering specialists, continues to push the boundaries of medical technology. “Their commitment to advancing patient care has led to the creation of iSTONE, a testament to the company’s dedication to innovation and excellence in healthcare,” stated Robert Allen, CFO of OmniGuide Holdings.

    The findings from the patient study, eagerly anticipated by the medical community, will be unveiled in the forthcoming months. OmniGuide Holdings is poised to lead the way in enhancing the safety, efficiency, and outcomes of kidney stone treatment, solidifying its position at the forefront of medical innovation.

    For more information about OmniGuide Holdings and the iSTONE™ technology, please visit https://www.omni-guide.com/news.

    1 Schlager, D., Schulte, A., Schütz, J., Brandenburg, A., Schell, C., Lamrini, S., Vogel, M., Teichmann, H.-O., & Miernik, A. (2021). Laser-guided real-time automatic target identification for endoscopic stone lithotripsy: a two-arm in vivo porcine comparison study. World Journal of Urology, 39, 2719-2726. https://doi.org/10.1007/s00345-020-03452-0

    Contact Information

    Tullio Cappelletto
    tcappelletto@omni-guide.com

    SOURCE: OmniGuide Holdings, Inc.

    View the original press release on newswire.com.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    Digi Power X Reports Q3 2026 Revenue Up 85% and AI Revenue Up Over 400% Compared to Q2

    November 13, 2026

    Otunnu Campaign Releases Profile of the Candidate

    November 5, 2026

    Chervon Names Thomas Scherer Vice President of Organizational Development – Sales, End User Marketing, and Service

    November 2, 2026

    Chervon Launches Advanced Momentum Program (AMP) to Hire & Develop the Next Generation of Leaders

    October 30, 2026

    U.S. Polo Assn. Executes Early on Europe’s Digital Product Passport Mandate

    October 29, 2026

    Chervon names Joel Petersheim as Vice President, End User Research and Sales – OPE Commercial USA

    October 26, 2026
    Latest News

    Africa CDC says Congo Ebola outbreak still not under control

    November 16, 2026

    UAE and Timor-Leste presidents discuss stronger bilateral ties

    November 16, 2026

    UAE President, Arab League chief discuss regional security

    November 14, 2026

    AfDB backs Morocco reforms and climate resilience with €434.4m

    November 14, 2026
    © 2026 Penang Herald | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.